Sugarbud Announces Option GrantHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Sugarbud Announces Option GrantCNW GroupJanuary 2, 2020ReblogShareTweetShareCALGARY , Jan. 2, 2020 /CNW/ - Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.WT) ("Sugarbud") is pleased to announce that as part of the corporation's long term incentive program, and pursuant to the terms and conditions of its stock option plan, the Sugarbud Board of Directors has approved the grant of 15,340,000 stock options to certain directors, officers, employees and consultants. The options expire five years from the date of grant and are exercisable at a price of $0.065 per common share. The options vest as to one third on the grant date and one third on each of the first and second anniversaries of the grant date. To facilitate the option grant, including 900,000 stock options to CEO and Director, John Kondrosky , certain directors have surrendered 6,750,000 options for cancellation, which were cancelled and returned for future grants under Sugarbud's stock option plan effective immediately.View photosSugarbud Craft Growers Corp. (CNW Group/Sugarbud Craft Growers Corp.)MoreAbout Sugarbud Sugarbud is a federally licensed Alberta -based publicly traded cannabis company focused on the cultivation and production of high-quality premium cannabis, and product leadership through the development, production and distribution of exceptional value-added cannabis products in Canada .http://www.sugarbud.ca/SOURCE Sugarbud Craft Growers Corp.View photosView original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2020/02/c4236.htmlReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoDoorDash Files Confidentially for IPOThe Wall Street JournalMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoA Rumored Gilead Takeover Offer Sent This Biotech Stock FlyingInvestor's Business DailyBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceBankrupt Boy Scouts may need to sell Norman Rockwell art to pay sexual abuse victimsUSA TODAYSomething 'dangerous' is happening beneath the surface of the market selloffYahoo FinanceCoronavirus won't stop Beyond Meat from entering China in 2020: CEO Ethan BrownYahoo Finance